The KHZE IPO announcement dated 8 Aug 2018 details exactly how the proposed IPO was to take place Unfortunately due to GMV's financial disposition, the Nasdaq Listing and HKZE Listing were both cancelled, or maybe in our case, postponed to a later date, as with the Nasdaq IPO. The HKZE IPO was for an initial $260,000,000.00 which was skewed GMV 70% and Guangzhou Yimei Innovative Science & Technology (GYIMSTC) 30%.
The IPO and subsequent listing on the HKZE possibly late this year or early next year to coincide with the Approval of the NMPA would give GMV multiple avenues to increase its market awareness and continue to grow globally as a company. If GMV was to list on the Nasdaq, these will be their competitors.
GMV's rivals are Bio Telemetry (BEAT) & iRhythm Technologies (IRTC)
BEAT listed in 2008 Shares 4,500,00.00 Price on listing $18.00 Total $81,000,000.00
IRTC listed 2016 Shares 6,294,118.00 Price on listing $17.00 Total 107,000,000.00
As you can see, GMV sitting at $0.11 would have to be one of the biggest and best buys on the market today. For the life of me I cannot understand why GMV's price is where its at. Take Beats SP on listing was $18.00. If GMV gets the listing on the HKZE, NASDAQ & ASX, that will be 3 stock markets. Do we think it will still be at $0.11. Up to you guys, cheap as chips. Buy them while they are affordable.
DYOR
GMV Price at posting:
10.5¢ Sentiment: Hold Disclosure: Held
